Skip to Main Content

Paper Details

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
Lancet Digit Health
15
2023
ALK, EGFR, NCSLC, NSCLC, PD-L1, cancer, non-small-cell lung cancer, patient, patients, tumour
Author NameAffiliation
Steven H LinThe University of Texas MD Anderson Cancer Center
Chao ChengInstitute for Clinical and Translational Research, Baylor College of Medicine
Chao ChengInstitute for Clinical and Translational Research, Baylor College of Medicine
Jianjun ZhangThe University of Texas MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2